Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00721695 · ClinicalTrials.gov registry record · Phase 1

Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.

A Phase 1 study of Cataract Extraction, sponsored by Omeros Corporation.

Completed
Registry status
Phase 1
Development phase
60
Enrollment target
4
Study locations

NCT00721695 is a Phase 1 study of Cataract Extraction that has completed, run by Omeros Corporation. The registered enrollment target is 60 participants, below the 92-participant average among 4 other Cataract Extraction trials with a reported enrollment target (35% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00721695, a Phase 1 study of Cataract Extraction, has completed, sponsored by Omeros Corporation.

COMPLETED
Registry status
Phase 1
Development phase
60 participants
Enrollment target
4
Study locations

Study Summary

This is an exploratory study to determine the safety and clinical benefit of OMS302 Injection in subjects undergoing Cataract Extraction with Lens Replacement (CELR) using a coaxial phacoemulsification process.

Conditions Studied

Cataract Extraction

Interventions

  • DRUG Vehicle
  • DRUG OMS302
  • DRUG OMS302-PE

Study Locations (4)

California

  • Shasta Eye Medical Group - Redding

Minnesota

  • Chu Vision Institute - Bloomington

Missouri

  • Silverstein Eye Centers - Kansas City

Wisconsin

  • Davis Duehr Dean - Madison

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2008-05
Est. Completion 2009-02
Phase Phase 1

Sponsor

Omeros Corporation

19 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00721695

The ClinicalTrials.gov registry entry for NCT00721695 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 4 other Cataract Extraction trials with a reported enrollment target (35% lower). The listed sponsor is Omeros Corporation, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cataract Extraction appearing as the primary indexed condition, and to 3 interventions - of which Vehicle is the first listed.

NCT00721695 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Minnesota, Missouri.

Frequently Asked Questions

What is clinical trial NCT00721695 about?

NCT00721695 is a clinical study titled "Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.". This is an exploratory study to determine the safety and clinical benefit of OMS302 Injection in subjects undergoing Cataract Extraction with Lens Replacement (CELR) using a coaxial phacoemulsification process.

What is the current status of trial NCT00721695?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2008-05. Estimated completion is 2009-02.

What conditions does trial NCT00721695 study?

This clinical trial studies the following conditions: Cataract Extraction.

What interventions are being tested in trial NCT00721695?

The interventions under investigation include: Vehicle (DRUG), OMS302 (DRUG), OMS302-PE (DRUG).

Who is sponsoring clinical trial NCT00721695?

This trial is sponsored by Omeros Corporation, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00721695 being conducted?

This trial has 4 study locations across California, Minnesota, Missouri, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cataract Extraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cataract Extraction

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.